Loomis, Sayles & Company
AMGN icon

Loomis, Sayles & Company’s Amgen AMGN Stock Holding History

Loomis, Sayles & Company’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$244K Buy
674
+37
+6% +$12.7K ﹤0.01% 547
2026
Q1 		$224K Sell
637
-31
-5% -$11.1K ﹤0.01% 560
2025
Q4 		$219K Sell
668
-24
-3% -$7.61K ﹤0.01% 540
2025
Q3 		$195K Sell
692
-134
-16% -$38.9K ﹤0.01% 522
2025
Q2 		$231K Buy
826
+16
+2% +$4.53K ﹤0.01% 519
2025
Q1 		$252K Buy
810
+269
+50% +$79.4K ﹤0.01% 513
2024
Q4 		$141K Sell
541
-313
-37% -$92.9K ﹤0.01% 542
2024
Q3 		$275K Buy
854
+53
+7% +$17.3K ﹤0.01% 504
2024
Q2 		$250K Sell
801
-3
-0.4% -$881 ﹤0.01% 515
2024
Q1 		$229K Sell
804
-147
-15% -$43K ﹤0.01% 511
2023
Q4 		$274K Sell
951
-83
-8% -$22.6K ﹤0.01% 486
2023
Q3 		$278K Sell
1,034
-113
-10% -$28.2K ﹤0.01% 491
2023
Q2 		$255K Sell
1,147
-204
-15% -$47.3K ﹤0.01% 514
2023
Q1 		$327K Buy
1,351
+439
+48% +$108K ﹤0.01% 492
2022
Q4 		$240K Sell
912
-803
-47% -$215K ﹤0.01% 500
2022
Q3 		$387K Buy
1,715
+1,647
+2,422% +$399K ﹤0.01% 437
2022
Q2 		$17K Sell
68
-20
-23% -$4.9K ﹤0.01% 608
2022
Q1 		$21K Sell
88
-13
-13% -$2.99K ﹤0.01% 629
2021
Q4 		$23K Sell
101
-53
-34% -$11.2K ﹤0.01% 671
2021
Q3 		$33K Sell
154
-2
-1% -$460 ﹤0.01% 626
2021
Q2 		$38K Buy
156
+5
+3% +$1.23K ﹤0.01% 598
2021
Q1 		$38K Sell
151
-5,467
-97% -$1.3M ﹤0.01% 579
2020
Q4 		$1.29M Buy
5,618
+1,560
+38% +$360K ﹤0.01% 473
2020
Q3 		$1.03M Sell
4,058
-2,383
-37% -$590K ﹤0.01% 444
2020
Q2 		$1.52M Sell
6,441
-3,290,789
-100% -$751M ﹤0.01% 425
2020
Q1 		$668M Sell
3,297,230
-182,745
-5% -$39.9M 1.38% 27
2019
Q4 		$839M Buy
3,479,975
+114,809
+3% +$25.3M 1.43% 26
2019
Q3 		$651M Buy
3,365,166
+33,302
+1% +$6.39M 1.25% 29
2019
Q2 		$614M Buy
3,331,864
+1,113
+0% +$199K 1.15% 32
2019
Q1 		$633M Buy
3,330,751
+14,985
+0.5% +$2.86M 1.24% 31
2018
Q4 		$645M Sell
3,315,766
-136,440
-4% -$26.6M 1.52% 24
2018
Q3 		$716M Buy
3,452,206
+60,875
+2% +$12M 1.4% 24
2018
Q2 		$626M Buy
3,391,331
+69,722
+2% +$12.3M 1.27% 25
2018
Q1 		$566M Buy
3,321,609
+5,159
+0.2% +$947K 1.2% 27
2017
Q4 		$577M Buy
3,316,450
+51,080
+2% +$9.04M 1.2% 27
2017
Q3 		$609M Buy
3,265,370
+77,724
+2% +$13.8M 1.33% 25
2017
Q2 		$549M Buy
3,187,646
+177,760
+6% +$28.9M 1.29% 25
2017
Q1 		$494M Buy
3,009,886
+8,865
+0.3% +$1.47M 1.23% 26
2016
Q4 		$439M Buy
3,001,021
+133,918
+5% +$20.2M 1.08% 29
2016
Q3 		$478M Buy
2,867,103
+117,217
+4% +$19.8M 1.21% 26
2016
Q2 		$418M Sell
2,749,886
-2,474
-0.1% -$385K 1.14% 29
2016
Q1 		$413M Buy
2,752,360
+175,727
+7% +$26.1M 1.17% 26
2015
Q4 		$418M Buy
2,576,633
+113,684
+5% +$17.9M 1.18% 26
2015
Q3 		$341M Buy
2,462,949
+160,776
+7% +$25.3M 1.01% 27
2015
Q2 		$353M Buy
2,302,173
+379,422
+20% +$60.8M 0.97% 27
2015
Q1 		$307M Sell
1,922,751
-192,213
-9% -$30.3M 0.85% 31
2014
Q4 		$337M Buy
2,114,964
+217,751
+11% +$33.9M 0.93% 23
2014
Q3 		$266M Buy
1,897,213
+200,400
+12% +$26.2M 0.78% 30
2014
Q2 		$201M Buy
1,696,813
+96,503
+6% +$11.2M 0.57% 36
2014
Q1 		$197M Buy
1,600,310
+459,577
+40% +$55.7M 0.56% 38
2013
Q4 		$130M Buy
1,140,733
+7,949
+0.7% +$904K 0.39% 56
2013
Q3 		$127M Buy
1,132,784
+616,432
+119% +$66.8M 0.41% 51
2013
Q2 		$50.9K Buy
+516,352
New +$53.6M 0.18% 131

Other funds holding AMGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Loomis, Sayles & Company's AMGN Position: Q2 2026 in Review

Loomis, Sayles & Company increased its Amgen (AMGN) stake by 5.8% in Q2 2026, buying an estimated $12.7K and bringing the position to 674 shares worth $244K. The position accounts for ﹤0.01% of the portfolio, ranked #547.

Loomis, Sayles & Company first reported a position in AMGN in Q2 2013 and has held it in 53 quarters since. The position peaked at $839M in Q4 2019. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Loomis, Sayles & Company held 674 shares of Amgen worth $244K as of Q2 2026.
  • Loomis, Sayles & Company bought 37 Amgen shares in Q2 2026, an estimated $12.7K.
  • Amgen made up ﹤0.01% of Loomis, Sayles & Company's portfolio in Q2 2026, its #547 holding.
  • Loomis, Sayles & Company first reported a position in Amgen in Q2 2013 and has held it in 53 quarters since.
  • Loomis, Sayles & Company's Amgen position peaked at $839M in Q4 2019.
  • 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Loomis, Sayles & Company's 13F filing for Q2 2026, filed 14 Aug 2026.